Mattson Financial Services LLC Lowers Position in HealthEquity, Inc. (NASDAQ:HQY)

Mattson Financial Services LLC lessened its stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 68.5% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,721 shares of the company's stock after selling 3,743 shares during the period. Mattson Financial Services LLC's holdings in HealthEquity were worth $165,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently modified their holdings of HQY. Wealthfront Advisers LLC acquired a new stake in HealthEquity in the 4th quarter valued at about $10,304,089,000. T. Rowe Price Investment Management Inc. purchased a new position in shares of HealthEquity during the 4th quarter worth approximately $78,107,000. Norges Bank acquired a new stake in HealthEquity during the 4th quarter worth approximately $74,701,000. Raymond James Financial Inc. acquired a new stake in HealthEquity during the 4th quarter worth approximately $45,728,000. Finally, Iron Triangle Partners LP acquired a new stake in HealthEquity during the 4th quarter worth $32,202,000. Institutional investors and hedge funds own 99.55% of the company's stock.

Insiders Place Their Bets

In related news, EVP Michael Henry Fiore sold 8,881 shares of the business's stock in a transaction that occurred on Friday, April 4th. The shares were sold at an average price of $78.26, for a total value of $695,027.06. Following the completion of the sale, the executive vice president now directly owns 56,655 shares in the company, valued at approximately $4,433,820.30. The trade was a 13.55% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Robert W. Selander sold 5,750 shares of the business's stock in a transaction that occurred on Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total transaction of $446,487.50. Following the completion of the sale, the director now owns 84,969 shares of the company's stock, valued at approximately $6,597,842.85. The trade was a 6.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.50% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on HQY shares. The Goldman Sachs Group cut their price target on shares of HealthEquity from $107.00 to $94.00 and set a "neutral" rating on the stock in a research note on Thursday, March 27th. Royal Bank of Canada started coverage on shares of HealthEquity in a research note on Thursday, May 22nd. They set an "outperform" rating and a $112.00 price target on the stock. KeyCorp cut their price target on shares of HealthEquity from $110.00 to $100.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 16th. Raymond James raised shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and lowered their price objective for the stock from $120.00 to $115.00 in a research report on Tuesday, March 25th. Finally, Barrington Research reaffirmed an "outperform" rating and issued a $112.00 target price on shares of HealthEquity in a report on Friday, April 11th. One research analyst has rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, HealthEquity has an average rating of "Buy" and a consensus price target of $112.33.

HealthEquity Price Performance

HQY stock traded up $0.13 during trading on Friday, reaching $101.11. 960,737 shares of the company were exchanged, compared to its average volume of 811,062. The company has a market cap of $8.75 billion, a P/E ratio of 92.76, a PEG ratio of 1.60 and a beta of 0.45. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $115.59. The stock's 50 day moving average price is $89.41 and its 200 day moving average price is $97.46. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.